Michael Overdorf
Förmögenhet: 989 828 $ per 2026-05-31
Förmögenhet: 989 828 $ per 2026-05-31
Michael Overdorf is Chief Business Officer & Executive Vice President at Annexon, Inc. since 2020.
Mr. Overdorf was Chief Operating Officer-Bio Medicines at Eli Lilly & Co. from 2001 to 2020.
Mr. Overdorf completed an undergraduate degree at Wabash College in 1992 and earned an MBA from Harvard Business School in 1999.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
ANNEXON, INC. 0,11 % | 2026-03-02 | 182 625 ( 0,11 % ) | 989 828 $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| ANNEXON, INC. | Företagsledare/Principal | 2020-07-30 |
| Företag | Position | Slut |
|---|---|---|
| ELI LILLY AND COMPANY | Företagsledare/Principal | 2020-07-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 4 |
|---|---|
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Annexon, Inc.
Annexon, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for neurodegenerative and autoimmune disorders | Health Technology |
Wabash College
Wabash College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Välj din utgåva
All finansiell information anpassad till den nationella nivån